-
Watson gets FDA nod for generic Lybrel
PARSIPPANY, N.J. — The Food and Drug Administration has approved a generic contraceptive made by Watson Pharmaceuticals, the company said Tuesday.
Watson announced the approval of levonorgestrel and ethinyl estradiol tablets in the 0.09-mg/0.02-mg strength.
The drug is a generic version of Pfizer’s Lybrel, which had sales of slightly less than $12 million during the 12-month period that ended in April, according to IMS Health.
-
Take Care joins forces with Jacksonville, Fla., health system
JACKSONVILLE, Fla. — Take Care Health Systems and Memorial Health on Tuesday announced a new relationship that will increase opportunities for clinical collaboration and improve patient access to high-quality, convenient and affordable healthcare options in the greater Jacksonville region.